Ozone therapy with local cellular immune modulation and disc progenitor cell implant is safe, effective and efficient
Low Back Pain (LBP) is a major cause of morbidity with significant economic impact through loss of work (15% in the United Kingdom). Additionally, there is the cost of health care and social support for the affected individual and their family.
It is estimated that more than half the population (49%- 70%) will experience significant LBP during their lives. Point prevalence from 12% to 30% is reported in western countries.
In patients with symptomatic DDD Ozone therapy, and Disc Progenitor Cells will be used to control LBP syndrome and recover the damaged vertebral and IVD structures. We hypothesized that ozone therapy, associated to local immune modulation, and local implant of Disc Progenitor Cells, has a synergic effect that will improve the results of the treatment of severe chronic degenerative disc disease.